Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Metabolically inactive insulin analog prevents type I diabetes in prediabetic NOD mice.
D G Karounos, … , J S Bryson, D A Cohen
D G Karounos, … , J S Bryson, D A Cohen
Published September 15, 1997
Citation Information: J Clin Invest. 1997;100(6):1344-1348. https://doi.org/10.1172/JCI119654.
View: Text | PDF
Research Article Article has an altmetric score of 6

Metabolically inactive insulin analog prevents type I diabetes in prediabetic NOD mice.

  • Text
  • PDF
Abstract

Research Article

Authors

D G Karounos, J S Bryson, D A Cohen

×

Total citations by year

Year: 2025 2024 2022 2021 2019 2018 2017 2016 2015 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 Total
Citations: 1 1 1 3 1 1 2 2 4 3 4 29 1 1 4 1 3 4 1 5 4 5 5 86
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (86)

Title and authors Publication Year
Evaluation of proinsulin(F25D) as a targeting ligand for insulin-binding B cells in autoimmune diabetes.
Apley KD, Bass LE, King J, Downes G, Wang K, Forchetti MV, Moore DJ, Kendall P, Bonami RH, Berkland CJ
Drug delivery and translational research 2025
An antigen-specific immunotherapeutic, AKS-107, deletes insulin-specific B cells and prevents murine autoimmune diabetes
Alleva DG, Delpero AR, Sathiyaseelan T, Murikipudi S, Lancaster TM, Atkinson MA, Wasserfall CH, Yu L, Ragupathy R, Bonami RH, Zion TC
Frontiers in immunology 2024
CX3CL1 Worsens Cardiorenal Dysfunction and Serves as a Therapeutic Target of Canagliflozin for Cardiorenal Syndrome
C Zheng, W Xuan, Z Chen, R Zhang, X Huang, Y Zhu, S Ma, K Chen, L Chen, M He, H Lin, W Liao, J Bin, Y Liao
Frontiers in pharmacology 2022
B Quiet: Autoantigen-Specific Strategies to Silence Raucous B Lymphocytes and Halt Cross-Talk with T Cells in Type 1 Diabetes
JL Felton, H Conway, RH Bonami
Biomedicines 2021
100 Years of insulin: Lifesaver, immune target, and potential remedy for prevention
A Ziegler, T Danne, C Daniel, E Bonifacio
The American Journal of Medicine 2021
Altered islet prohormone processing: A cause or consequence of diabetes?
A Ramzy, TJ Kieffer
Physiological reviews 2021
Case Reports of Pre-clinical Replication Studies in Metabolism and Diabetes
M von Herrath, PP Pagni, K Grove, G Christoffersson, M Tang-Christensen, AE Karlsen, JS Petersen
Cell Metabolism 2019
The Development of Immunotherapy Strategies for the Treatment of Type 1 Diabetes
K Coppieters, M von Herrath
Frontiers in Medicine 2018
Metabolically inactive insulin analogue does not prevent autoimmune diabetes in NOD mice
J Grönholm, PP Pagni, MN Pham, CB Gibson, PF Macomber, JL Vela, M Herrath, MJ Lenardo
Diabetologia 2017
Metabolically inactive insulin: friend or foe in the prevention of autoimmune diabetes?
M Knip
Diabetologia 2017
Oral insulin (human, murine, or porcine) does not prevent diabetes in the non-obese diabetic mouse
MN Pham, C Gibson, AK Rydén, N Perdue, TE Boursalian, PP Pagni, K Coppieters, C Skonberg, T Porsgaard, M Herrath, JL Vela
Clinical Immunology 2016
Analysis of antigen specific T cells in diabetes – Lessons from pre-clinical studies and early clinical trials
B Krishnamurthy, C Selck, J Chee, G Jhala, TW Kay
Journal of Autoimmunity 2016
Progress in Molecular Biology and Translational Science
V Ovcinnikovs, LS Walker
Progress in molecular biology and translational science 2015
A combination dual-sized microparticle system modulates dendritic cells and prevents type 1 diabetes in prediabetic NOD mice
JS Lewis, NV Dolgova, Y Zhang, CQ Xia, CH Wasserfall, MA Atkinson, MJ Clare-Salzler, BG Keselowsky
Clinical Immunology 2015
Novel diagnostic and therapeutic approaches for autoimmune diabetes — A prime time to treat insulitis as a disease
J Grönholm, MJ Lenardo
Clinical Immunology 2015
The Effect of DPT-1 Intravenous Insulin Infusion and Daily Subcutaneous Insulin on Endogenous Insulin Secretion and Postprandial Glucose Tolerance
W Hao, CJ Greenbaum, JP Krischer, D Cuthbertson, JB Marks, JP Palmer
Diabetes care 2015
Short-term subcutaneous insulin treatment delays but does not prevent diabetes in NOD mice: Immunomodulation
V Brezar, S Culina, MC Gagnerault, R Mallone
European Journal of Immunology 2012
MECHANISMS IN ENDOCRINOLOGY: Insulin and type 1 diabetes: immune connections
S Culina, V Brezar, R Mallone
European Journal of Endocrinology 2012
The Immunological Barriers to Regenerative Medicine
PJ Fairchild
2012
Antigen-Based Immune Therapeutics for Type 1 Diabetes: Magic Bullets or Ordinary Blanks?
S Culina, C Boitard, R Mallone
Clinical and Developmental Immunology 2011
Beyond the Hormone: Insulin as an Autoimmune Target in Type 1 Diabetes
V Brezar, JC Carel, C Boitard, R Mallone
Endocrine reviews 2011
Impact of Intranasal Insulin on Insulin Antibody Affinity and Isotypes in Young Children With HLA-Conferred Susceptibility to Type 1 Diabetes
SJ Ryhanen, T Harkonen, H Siljander, K Nanto-Salonen, T Simell, H Hyoty, J Ilonen, R Veijola, O Simell, M Knip
Diabetes care 2011
Otelixizumab: a novel agent for the prevention of type 1 diabetes mellitus
SA Miller, ES Onge
Expert Opinion on Biological Therapy 2011
The Islets of Langerhans
S Islam
2010
The Islets of Langerhans
S Islam
2010
The Islets of Langerhans
S Islam
2010
The Islets of Langerhans
S Islam
2010
The Islets of Langerhans
S Islam
2010
The Islets of Langerhans
S Islam
2010
The Islets of Langerhans
S Islam
2010
The Islets of Langerhans
S Islam
2010
The Islets of Langerhans
S Islam
2010
The Islets of Langerhans
S Islam
2010
The Islets of Langerhans
S Islam
2010
The Islets of Langerhans
S Islam
2010
The Islets of Langerhans
S Islam
2010
The Islets of Langerhans
S Islam
2010
The Islets of Langerhans
S Islam
2010
The Islets of Langerhans
S Islam
2010
The Islets of Langerhans
S Islam
2010
The Islets of Langerhans
S Islam
2010
The Islets of Langerhans
S Islam
2010
The Islets of Langerhans
S Islam
2010
The Islets of Langerhans
S Islam
2010
The Islets of Langerhans
S Islam
2010
The Islets of Langerhans
S Islam
2010
The Islets of Langerhans
S Islam
2010
The Islets of Langerhans
S Islam
2010
The Islets of Langerhans
S Islam
2010
The Islets of Langerhans
S Islam
2010
Immune therapy for type 1 diabetes mellitus—what is unique about anti-CD3 antibodies?
L Chatenoud
Nature Reviews Endocrinology 2010
Immunotherapy of type 1 diabetes — How to rationally prioritize combination therapies in T1D
T Boettler, M Herrath
International Immunopharmacology 2010
Immunotherapy for the Prevention and Treatment of Type 1 Diabetes: Optimizing the path from bench to bedside
D Bresson, M Herrath
Diabetes care 2009
Nasal insulin to prevent type 1 diabetes in children with HLA genotypes and autoantibodies conferring increased risk of disease: a double-blind, randomised controlled trial
K Näntö-Salonen, A Kupila, S Simell, H Siljander, T Salonsaari, A Hekkala, S Korhonen, R Erkkola, JI Sipilä, L Haavisto, M Siltala, J Tuominen, J Hakalax, H Hyöty, J Ilonen, R Veijola, T Simell, M Knip, O Simell
The Lancet 2008
CD3-specific antibodies: a portal to the treatment of autoimmunity
L Chatenoud, JA Bluestone
Nature Reviews Immunology 2007
Preventive Interventions for Type 1 Diabetes: History, Appraisal and Prospects
John Dupre, L. Jeffrey, Mahon
Canadian Journal of Diabetes 2007
Immunological Responses to Exogenous Insulin
SE Fineberg, TT Kawabata, D Finco-Kent, RJ Fountaine, GL Finch, AS Krasner
Endocrine reviews 2007
Immune Regulation and Immunotherapy in Autoimmune Disease
J Zhang
2007
TGF-beta Signaling is Required for the Function of Insulin Reactive T Regulatory Cells
Wei Du, F. Susan Wong, Ming O. Li, Jian Peng, Hao Qi, Richard A. Flavell, Robert Sherwin and Li Wen
Journal of Clinical Investigation 2006
A Comprehensive Review of Interventions in the NOD Mouse and Implications for Translation
LK Shoda, DL Young, S Ramanujan, CC Whiting, MA Atkinson, JA Bluestone, GS Eisenbarth, D Mathis, AA Rossini, SE Campbell, R Kahn, HT Kreuwel
Immunity 2005
Animal models of diabetes mellitus
DA Rees, JC Alcolado
Diabetic Medicine 2005
Expression of cholera toxin B subunit and the B chain of human insulin as a fusion protein in transgenic tobacco plants
D Li, J OLeary, Y Huang, NP Huner, AM Jevnikar, S Ma
Plant Cell Reports 2005
Molecular Pathways Altered by Insulin B9-23 Immunization
SE Eckenrode, QG Ruan, CD Collins, P Yang, RA Mcindoe, A Muir, JX She
Annals of the New York Academy of Sciences 2004
Preservation of C-peptide secretion in subjects at high risk of developing type 1 diabetes mellitus - a new surrogate measure of non-progression?
D Schatz, D Cuthbertson, M Atkinson, MC Salzler, W Winter, A Muir, J Silverstein, R Cook, N Maclaren, JX She, C Greenbaum, J Krischer
Pediatric Diabetes 2004
Neuroendocrine Immuno-ontogeny of the Pathogenesis of Autoimmune Diabetes in the Nonobese Diabetic (NOD) Mouse
F Homo-Delarche
ILAR journal / National Research Council, Institute of Laboratory Animal Resources 2004
Gene expression profiles define a key checkpoint for type 1 diabetes in NOD mice
Sarah E Eckenrode, Qingguo Ruan, Ping Yang, Weipeng Zheng, Richard A McIndoe, Jin-Xiong She
Diabetes 2004
Characterization of antibody responses to endogenous and exogenous antigen in the nonobese diabetic mouse
K Koczwara, M Schenker, S Schmid, K Kredel, AG Ziegler, E Bonifacio
Clinical Immunology 2003
Immunomodulatory vaccination in autoimmune disease
I Urbanek-Ruiz, PJ Ruiz, L Steinman, CG Fathman
Endocrinology & Metabolism Clinics of North America 2002
Islet abnormalities in the pathogenesis of autoimmune diabetes
JG Rosmalen, PJ Leenen, C Pelegri, HA Drexhage, F Homo-Delarche
Trends in Endocrinology & Metabolism 2002
Restricted islet-cell reactive T cell repertoire of early pancreatic islet infiltrates in NOD mice
FJ Baker, M Lee, Y Chien, MM Davis
Proceedings of the National Academy of Sciences 2002
Inhaled Insulin and Insulin Antibodies: A New Twist to an Old Debate
JA Stoever, JP Palmer
Diabetes Technology & Therapeutics 2002
Immunotherapy of type 1 diabetes: lessons for other autoimmune diseases
JF Bach
Arthritis research 2002
TOLERANCE TOISLETAUTOANTIGENS INTYPE1 DIABETES
JF Bach, L Chatenoud
Annual Review of Immunology 2001
New therapeutic approaches to type 1 diabetes: from prevention to cellular or gene therapies
C Thivolet
Clinical Endocrinology 2001
Pathophysiology of Immune-Mediated (Type 1) Diabetes Mellitus
M Abel, M Krokowski
BioDrugs 2001
Recombinant DNA Technology in the Treatment of Diabetes: Insulin Analogs
Z Vajo, J Fawcett, WC Duckworth
Endocrine reviews 2001
Does GAD Have a Unique Role in Triggering IDDM?
S Baekkeskov, J Kanaani, JC Jaume, S Kash
Journal of Autoimmunity 2000
The molecular specificity of insulin autoantibodies
KN Potter, TJ Wilkin
Diabetes/Metabolism Research and Reviews 2000
Islet Abnormalities Associated with an Early Influx of Dendritic Cells and Macrophages in NOD and NODscid Mice
JG Rosmalen, F Homo-Delarche, S Durant, M Kap, PJ Leenen, HA Drexhage
Laboratory Investigation 2000
Prevention of Type 1 Diabetes: Is Now the Time?1
DJ Becker, RE LaPorte, I Libman, M Pietropaolo, HM Dosch
The Journal of clinical endocrinology and metabolism 2000
Multiple Genes/Multiple Autoantigens Role in Type 1 Diabetes
N Abiru, GS Eisenbarth
Clinical Reviews in Allergy & Immunology 2000
Pathogenesis, prediction and trials for the prevention of insulin-dependent (type 1) diabetes mellitus1Abbreviations: s.c., subcutaneous; i.p., intraperitoneal; i.v., intravenous; IFA, incomplete Freund's adjuvant; DTP, diphtheria-tetanus-pertussis; LCMV, lymphocytic choriomeningitis virus; GAD, glutamic acid decarboxylase; ICA, islet cell autoantibody; JDF, juvenile diabetes foundation; IAA, insulin autoantibody; GAA, glutamic acid decarboxylase autoantibody; DM, diabetes mellitus; RIA, radioimmunoassay; AA, autoantibody; kD, kilodalton; FPIR, first phase insulin release; IIF, indirect immunofluoresence; IGT, impaired glucose tolerance; OGT, oral glucose tolerance.1
PM Graves, GS Eisenbarth
Advanced Drug Delivery Reviews 1999
Transgenes and knockout mutations in animal models of type 1 diabetes and multiple sclerosis
FS Wong, BN Dittel, CA Janeway
Immunological Reviews 1999
Insulin-dependent diabetes mellitus and its animal models
FS Wong, CA Janeway
Current Opinion in Immunology 1999
Effects of insulin administration in a group of high-risk, non-diabetic, first-degree relatives of Type 1 diabetic patients: an open pilot trial
C Rodriguez-Villar, I Conget, R Casamitjana, G Ercilla, R Gomis
Diabetic Medicine 1999
Antigen-based immunotherapy for autoimmune disease: from animal models to humans?
J Tian, A Olcott, L Hanssen, D Zekzer, DL Kaufman
Immunology Today 1999

← Previous 1 2 3 4 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Referenced in 14 patents
22 readers on Mendeley
See more details